Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014403 |
| CAS No | NA |
| Mol.F. | C16H21ClN4O |
| Mol.Wt. | 320.8 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014404 |
| CAS No | NA |
| Mol.F. | C18H20BrN3OS |
| Mol.Wt. | 406.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014405 |
| CAS No | NA |
| Mol.F. | C16H19N3O2 |
| Mol.Wt. | 285.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014406 |
| CAS No | NA |
| Mol.F. | C15H17N3O |
| Mol.Wt. | 255.31 |
| INV STATUS | In Stock |
| CAT No | SRC-N014407 |
| CAS No | NA |
| Mol.F. | C6H4BrN5O3 |
| Mol.Wt. | 274.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014408 |
| CAS No | 78658-62-5 |
| Mol.F. | C10H14N2O3 |
| Mol.Wt. | 210.23 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014409 |
| CAS No | 1850-61-9 |
| Mol.F. | C10H14N2O2 |
| Mol.Wt. | 194.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014410 |
| CAS No | 73829-38-6 |
| Mol.F. | C12H14N4O2 |
| Mol.Wt. | 246.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014411 |
| CAS No | 1216880-64-6 |
| Mol.F. | C17H24N4O3S |
| Mol.Wt. | 364.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014412 |
| CAS No | 145438-96-6 |
| Mol.F. | C7H11N5O2 |
| Mol.Wt. | 197.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014413 |
| CAS No | 145438-97-7 |
| Mol.F. | C7H10N6O3 |
| Mol.Wt. | 226.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014415 |
| CAS No | NA |
| Mol.F. | C18H22N2O4 |
| Mol.Wt. | 330.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014416 |
| CAS No | NA |
| Mol.F. | C13H18N2O4 |
| Mol.Wt. | 266.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014417 |
| CAS No | NA |
| Mol.F. | C17H18N2O |
| Mol.Wt. | 266.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014418 |
| CAS No | NA |
| Mol.F. | C17H17ClN2O |
| Mol.Wt. | 300.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014414 |
| CAS No | NA |
| Mol.F. | C25H27N7O5 |
| Mol.Wt. | 505.5 g/mol |
| INV STATUS | In Stock |